| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963575 | Vaccine | 2015 | 6 Pages |
Abstract
Compared to IIV-SD, IIV-HD reduced the risk of SAEs possibly related to influenza. The observed relative effectiveness against serious pneumonia is particularly noteworthy considering the burden of influenza and pneumonia in older adults.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Carlos A. DiazGranados, Corwin A. Robertson, H. Keipp Talbot, Victoria Landolfi, Andrew J. Dunning, David P. Greenberg,